Literature DB >> 21323691

Flow cytometric analysis of TCR Vβ repertoire in patients with 22q11.2 deletion syndrome.

A McLean-Tooke1, D Barge, G P Spickett, A R Gennery.   

Abstract

In 22q11.2 deletion patients, the normal decrease in T lymphocyte counts after 1-2 years is blunted such that relatively T lymphocyte numbers increase over early childhood, probably via post-thymic expansion of peripheral lymphocytes. This may leave less T lymphocyte receptor (TCR) diversity than when derived from naive thymic emigrants. We analysed TCR Vβ repertoire on 27 22q11.2 chromosome deletion patients. No patient had infection at sampling. CD3(+) CD4(+) recent thymic emigrants (RTEs) were identified by CD45RA and CD31 expression. TCR Vβ repertoire was determined using four-colour flow cytometry. Patients and controls showed significant TCR Vβ family usage differences between CD3(+) CD4(+) and CD3(+) CD4(-) T lymphocyte subpopulations. Vβ family abnormalities (±3 SD of controls) were identified in 18/27 (67%) patients and 12/47 (25%) controls. In patients, the magnitude of expansions was increased, with some Vβ families representing 37% of the cells present in the subpopulations. There was a significant increase in frequency of abnormalities in CD3(+) CD4(+) (P < 0.001) and CD3(+) CD4(-) T lymphocytes (P < 0.05) in patients. A total of 11/16 patients had an abnormal CD4(+) CD25(Bright) TCR Vβ repertoire. There was no difference in expansions/contractions between CD4(+) CD25(Bright) and CD4(+) T lymphocyte repertoires (P = 0.575) for individual patients but significant differences in expansions/contractions between CD4(+) CD25(Bright) and CD8(+) T lymphocytes repertoires (P = 0.011). There was bias in Vβ usage between CD3(+) CD4(+) and CD3(+) CD4(-) T lymphocyte subsets. A total of 67% patients had TCR Vβ repertoire abnormalities, with a trend towards increased repertoire abnormalities with fewer RTEs, suggesting thymic output plays an important role in TCR repertoire diversity. There was no correlation between skewed repertoire and symptoms of infection or autoimmunity.
© 2011 The Authors. Scandinavian Journal of Immunology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21323691     DOI: 10.1111/j.1365-3083.2011.02527.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  High-throughput T cell receptor sequencing reveals distinct repertoires between tumor and adjacent non-tumor tissues in HBV-associated HCC.

Authors:  Yunqing Chen; Ying Xu; Miaoxian Zhao; Yu Liu; Mingxing Gong; Cantao Xie; Hongkai Wu; Zhanhui Wang
Journal:  Oncoimmunology       Date:  2016-08-05       Impact factor: 8.110

Review 2.  Gene/cell therapy approaches for Immune Dysregulation Polyendocrinopathy Enteropathy X-linked syndrome.

Authors:  Laura Passerini; Francesca R Santoni de Sio; Matthew H Porteus; Rosa Bacchetta
Journal:  Curr Gene Ther       Date:  2014       Impact factor: 4.391

Review 3.  T Cell Repertoire During Ontogeny and Characteristics in Inflammatory Disorders in Adults and Childhood.

Authors:  Svenja Foth; Sara Völkel; Daniel Bauersachs; Michael Zemlin; Chrysanthi Skevaki
Journal:  Front Immunol       Date:  2021-02-09       Impact factor: 7.561

Review 4.  Inborn errors of thymic stromal cell development and function.

Authors:  Alexandra Y Kreins; Stefano Maio; Fatima Dhalla
Journal:  Semin Immunopathol       Date:  2020-11-30       Impact factor: 9.623

5.  Long-Term Follow-Up of Newborns with 22q11 Deletion Syndrome and Low TRECs.

Authors:  Jenny Lingman Framme; Christina Lundqvist; Anna-Carin Lundell; Pauline A van Schouwenburg; Andri L Lemarquis; Karolina Thörn; Susanne Lindgren; Judith Gudmundsdottir; Vanja Lundberg; Sofie Degerman; Rolf H Zetterström; Stephan Borte; Lennart Hammarström; Esbjörn Telemo; Magnus Hultdin; Mirjam van der Burg; Anders Fasth; Sólveig Oskarsdóttir; Olov Ekwall
Journal:  J Clin Immunol       Date:  2022-01-26       Impact factor: 8.542

6.  Immune Dysfunction in Children with CHARGE Syndrome: A Cross-Sectional Study.

Authors:  Monica T Y Wong; Annechien J A Lambeck; Mirjam van der Burg; Sacha la Bastide-van Gemert; Lianne A Hogendorf; Conny M A van Ravenswaaij-Arts; Elisabeth H Schölvinck
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

Review 7.  Immunodeficiency in DiGeorge Syndrome and Options for Treating Cases with Complete Athymia.

Authors:  E Graham Davies
Journal:  Front Immunol       Date:  2013-10-31       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.